{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,15]],"date-time":"2026-03-15T07:20:03Z","timestamp":1773559203313,"version":"3.50.1"},"reference-count":29,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"vor","delay-in-days":366,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100018925","name":"Henan Province Health and Family Planning Commission","doi-asserted-by":"publisher","award":["232102310201"],"award-info":[{"award-number":["232102310201"]}],"id":[{"id":"10.13039\/100018925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100018925","name":"Henan Province Health and Family Planning Commission","doi-asserted-by":"publisher","award":["LHGJ20220186"],"award-info":[{"award-number":["LHGJ20220186"]}],"id":[{"id":"10.13039\/100018925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100018925","name":"Henan Province Health and Family Planning Commission","doi-asserted-by":"publisher","award":["SBGJ202102069"],"award-info":[{"award-number":["SBGJ202102069"]}],"id":[{"id":"10.13039\/100018925","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Transplantation and Cellular Therapy"],"published-print":{"date-parts":[[2023,12]]},"DOI":"10.1016\/j.jtct.2023.09.015","type":"journal-article","created":{"date-parts":[[2023,9,24]],"date-time":"2023-09-24T08:13:34Z","timestamp":1695543214000},"page":"771.e1-771.e10","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Haploidentical Cord Blood Transplantation with 8 mg\/kg Antithymocyte Globulin as Graft-versus-Host Disease Prophylaxis Compared to Haploidentical Transplantation with 10 mg\/kg Antithymocyte Globulin in the Treatment of Acute Leukemia"],"prefix":"10.1016","volume":"29","author":[{"given":"Fangfang","family":"Yuan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gangping","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Minghui","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xudong","family":"Wei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7379-3820","authenticated-orcid":false,"given":"Yuewen","family":"Fu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jtct.2023.09.015_bib0001","first-page":"640","article-title":"Early hematopoietic recovery after single unit unrelated cord blood transplantation in adults supported by co-infusion of mobilized stem cells from a third-party donor","volume":"91","author":"Magro","year":"2006","journal-title":"Haematologica."},{"key":"10.1016\/j.jtct.2023.09.015_bib0002","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1038\/bmt.2008.329","article-title":"Cord blood transplants supported by co-infusion of mobilized hematopoietic stem cells from a third-party donor","volume":"43","author":"Bautista","year":"2009","journal-title":"Bone Marrow Transplant."},{"key":"10.1016\/j.jtct.2023.09.015_bib0003","doi-asserted-by":"crossref","first-page":"6438","DOI":"10.1182\/blood-2011-08-372508","article-title":"Reduced-intensity conditioning with combined haploidentical and cord blood transplantation results in rapid engraftment, low GVHD, and durable remissions","volume":"118","author":"Liu","year":"2011","journal-title":"Blood."},{"key":"10.1016\/j.jtct.2023.09.015_bib0004","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1016\/j.bbmt.2017.12.794","article-title":"Reduced intensity allogeneic transplant for acute myeloid leukemia and myelodysplastic syndrome using combined CD34-selected haploidentical graft and a single umbilical cord unit compared to matched unrelated donor stem cells in older adults","volume":"24","author":"Tsai","year":"2018","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.jtct.2023.09.015_bib0005","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1038\/bmt.2013.154","article-title":"Combination of a haploidentical SCT with an unrelated cord blood unit: a single-arm prospective study","volume":"49","author":"Chen","year":"2014","journal-title":"Bone Marrow Transplant."},{"key":"10.1016\/j.jtct.2023.09.015_bib0006","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.trsl.2007.06.003","article-title":"Pathophysiology of acute graft-versus-host disease: recent advances","volume":"150","author":"Sun","year":"2007","journal-title":"Transl Res."},{"key":"10.1016\/j.jtct.2023.09.015_bib0007","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1007\/s00277-004-0890-7","article-title":"Immunopathogenesis of acute graft-versus-host disease: implications for novel preventive and therapeutic strategies","volume":"83","author":"Zeiser","year":"2004","journal-title":"Ann Hematol."},{"key":"10.1016\/j.jtct.2023.09.015_bib0008","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1016\/j.bbmt.2014.11.676","article-title":"Rabbit anti-T cell globulin in allogeneic hematopoietic cell transplantation","volume":"21","author":"Storek","year":"2015","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.jtct.2023.09.015_bib0009","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1186\/s12916-019-1393-7","article-title":"Two dose levels of rabbit antithymocyte globulin as graft-versus-host disease prophylaxis in haploidentical stem cell transplantation: a multicenter randomized study","volume":"17","author":"Lin","year":"2019","journal-title":"BMC Med."},{"key":"10.1016\/j.jtct.2023.09.015_bib0010","doi-asserted-by":"crossref","first-page":"3664","DOI":"10.1182\/blood-2014-01-552984","article-title":"Validation and refinement of the Disease Risk Index for allogeneic stem cell transplantation","volume":"123","author":"Armand","year":"2014","journal-title":"Blood."},{"key":"10.1016\/j.jtct.2023.09.015_bib0011","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1186\/s13045-016-0265-2","article-title":"How do we choose the best donor for T-cell-replete, HLA-haploidentical transplantation?","volume":"9","author":"Chang","year":"2016","journal-title":"J Hematol Oncol."},{"key":"10.1016\/j.jtct.2023.09.015_bib0012","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1038\/s41409-017-0062-8","article-title":"The European Society for Blood and Marrow Transplantation (EBMT) consensus guidelines for the detection and treatment of donor-specific anti-HLA antibodies (DSA) in haploidentical hematopoietic cell transplantation","volume":"53","author":"Ciurea","year":"2018","journal-title":"Bone Marrow Transplant."},{"key":"10.1016\/j.jtct.2023.09.015_bib0013","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.1038\/s41409-018-0204-7","article-title":"EBMT-NIH-CIBMTR Task Force position statement on standardized terminology & guidance for graft-versus-host disease assessment","volume":"53","author":"Schoemans","year":"2018","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jtct.2023.09.015_bib0014","first-page":"825","article-title":"1994 Consensus Conference on Acute GVHD Grading","volume":"15","author":"Przepiorka","year":"1995","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jtct.2023.09.015_bib0015","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/j.bbmt.2014.12.001","article-title":"National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: I. The 2014 Diagnosis and Staging Working Group report","volume":"21","author":"Jagasia","year":"2015","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.jtct.2023.09.015_bib0016","doi-asserted-by":"crossref","first-page":"3784","DOI":"10.1182\/blood-2007-03-082933","article-title":"Late mortality after allogeneic hematopoietic cell transplantation and functional status of long-term survivors: report from the Bone Marrow Transplant Survivor Study","volume":"110","author":"Bhatia","year":"2007","journal-title":"Blood."},{"key":"10.1016\/j.jtct.2023.09.015_bib0017","doi-asserted-by":"crossref","first-page":"1774","DOI":"10.1016\/j.bbmt.2018.07.012","article-title":"Multifaceted burden of chronic graft-versus-host disease","volume":"24","author":"Radojcic","year":"2018","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.jtct.2023.09.015_bib0018","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1620\/tjem.239.193","article-title":"Donor-derived regulatory T cells attenuate the severity of acute graft-versus-host disease after cord blood transplantation","volume":"239","author":"Zou","year":"2016","journal-title":"Tohoku J Exp Med."},{"key":"10.1016\/j.jtct.2023.09.015_bib0019","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1038\/bmt.2017.36","article-title":"Haplo-cord transplantation compared to haploidentical transplantation with post-transplant cyclophosphamide in patients with AML","volume":"52","author":"Kwon","year":"2017","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jtct.2023.09.015_bib0020","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1016\/j.clim.2008.02.008","article-title":"Umbilical cord blood transplantation: basic biology and clinical challenges to immune reconstitution","volume":"127","author":"Brown","year":"2008","journal-title":"Clin Immunol."},{"key":"10.1016\/j.jtct.2023.09.015_bib0021","doi-asserted-by":"crossref","first-page":"1460","DOI":"10.1016\/j.bbmt.2011.02.001","article-title":"Serious infection risk and immune recovery after double-unit cord blood transplantation without antithymocyte globulin","volume":"17","author":"Sauter","year":"2011","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.jtct.2023.09.015_bib0022","doi-asserted-by":"crossref","first-page":"4111","DOI":"10.1182\/blood-2009-09-244145","article-title":"Clearance of CMV viremia and survival after double umbilical cord blood transplantation in adults depends on reconstitution of thymopoiesis","volume":"115","author":"Brown","year":"2010","journal-title":"Blood."},{"key":"10.1016\/j.jtct.2023.09.015_bib0023","doi-asserted-by":"crossref","first-page":"1877","DOI":"10.1007\/s00277-019-03715-w","article-title":"Virus reactivation and low dose of CD34+ cells, rather than haploidentical transplantation, were associated with secondary poor graft function within the first 100 days after allogeneic stem cell transplantation","volume":"98","author":"Sun","year":"2019","journal-title":"Ann Hematol."},{"key":"10.1016\/j.jtct.2023.09.015_bib0024","first-page":"557","article-title":"[Optimization of ATG dose in haploid hematopoietic stem cell transplantation for hematologic malignancies]","volume":"41","author":"Zhou","year":"2020","journal-title":"Zhonghua Xue Ye Xue Za Zhi"},{"key":"10.1016\/j.jtct.2023.09.015_bib0025","doi-asserted-by":"crossref","first-page":"2203","DOI":"10.1056\/NEJMc1612872","article-title":"Cord-blood transplantation in patients with minimal residual disease","volume":"375","author":"Gupta","year":"2016","journal-title":"N Engl J Med."},{"key":"10.1016\/j.jtct.2023.09.015_bib0026","doi-asserted-by":"crossref","first-page":"1985","DOI":"10.1016\/j.bbmt.2015.07.029","article-title":"High disease-free survival with enhanced protection against relapse after double-unit cord blood transplantation when compared with T cell-depleted unrelated donor transplantation in patients with acute leukemia and chronic myelogenous leukemia","volume":"21","author":"Ponce","year":"2015","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.jtct.2023.09.015_bib0027","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.bbmt.2018.09.002","article-title":"Cord haploidentical non-in vitro T cell depletion allogeneic hematopoietic stem cell transplantation reduces relapse of refractory acute leukemia","volume":"25","author":"Wang","year":"2019","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.jtct.2023.09.015_bib0028","doi-asserted-by":"crossref","first-page":"2509","DOI":"10.1073\/pnas.1119541109","article-title":"Indirect evidence that maternal microchimerism in cord blood mediates a graft-versus-leukemia effect in cord blood transplantation","volume":"109","author":"van Rood","year":"2012","journal-title":"Proc Natl Acad Sci U S A."},{"key":"10.1016\/j.jtct.2023.09.015_bib0029","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1038\/s41409-020-01149-x","article-title":"Cord blood maternal microchimerism following unrelated cord blood transplantation","volume":"56","author":"Kanaan","year":"2021","journal-title":"Bone Marrow Transplant"}],"container-title":["Transplantation and Cellular Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666636723015543?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666636723015543?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,13]],"date-time":"2025-11-13T03:11:14Z","timestamp":1763003474000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2666636723015543"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12]]},"references-count":29,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2023,12]]}},"alternative-id":["S2666636723015543"],"URL":"https:\/\/doi.org\/10.1016\/j.jtct.2023.09.015","relation":{},"ISSN":["2666-6367"],"issn-type":[{"value":"2666-6367","type":"print"}],"subject":[],"published":{"date-parts":[[2023,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Haploidentical Cord Blood Transplantation with 8 mg\/kg Antithymocyte Globulin as Graft-versus-Host Disease Prophylaxis Compared to Haploidentical Transplantation with 10 mg\/kg Antithymocyte Globulin in the Treatment of Acute Leukemia","name":"articletitle","label":"Article Title"},{"value":"Transplantation and Cellular Therapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jtct.2023.09.015","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The American Society for Transplantation and Cellular Therapy. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}